揭开硫福拉的营养面:主要关注葡萄糖恒温调节
Yanan Wang1,2, Xiaoyun He1,2, Nan Cheng1,2
1Key Laboratory of Precision Nutrition and Food Quality, Key Laboratory of Functional Dairy, Ministry of Education, College of Food Science and Nutritional Engineering, China Agricultural University, Beijing 100083, China.
Nutrients
|June 27, 2024
概括
花中的一种化合物硫福拉 (SFN) 有效地改善葡萄糖平衡,具有低毒性. 这项研究探讨了其机制和在食品和药品中的潜在用途.
科学领域:
- 营养科学 营养科学
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 异常的葡萄糖平衡与诸如心血管疾病,高血压,2型糖尿病和肥胖等代谢综合征有关.
- 保持平衡的葡萄糖水平对于最佳的生物功能至关重要.
- 花中的一个关键化合物硫福拉 (SFN) 在增强葡萄糖平衡中具有极小的细胞毒性.
研究的目的:
- 评估硫黄 (SFN) 对葡萄糖平衡的影响.
- 阐明SFN调节效应背后的分子机制.
- 审查提高SFN生物可用性和安全性的战略.
主要方法:
- 在体外研究中的研究.
- 在生物体内进行的研究.
- 人类临床试验的人类临床试验
主要成果:
- 在各种研究模型中,SFN对葡萄糖平衡有显著的影响.
- 研究了SFN调节葡萄糖作用的分子机制.
- 提出了改善SFN生物可用性和输送的策略.
结论:
- 通过明确的机制,SFN通过明确的机制对葡萄糖平衡产生有利影响.
- 它在饮食中的丰富性和安全性支持潜在的应用.
- 对于食品和制药行业来说,SFN在管理代谢健康方面表现有前途.
相关概念视频
Glucose Homeostasis: Regulation of Blood Glucose
1.6K
Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
1.6K
Oral Hypoglycemic Agents: Sulfonylureas
199
Sulfonylureas are oral hypoglycemic agents utilized in treating type 2 diabetes. They are characterized by their unique sulfonylurea chemical structure. The family of sulfonylureas is divided into generations. First-generation sulfonylureas, including tolbutamide (Orinase), chlorpropamide (Diabinese), and tolazamide (Tolinase), trigger insulin release from pancreatic β cells and enhance peripheral tissues' insulin sensitivity. The second-generation members, such as glipizide...
199
Hormones Regulating Blood Glucose
3.2K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
3.2K
Overview of Carbohydrate Metabolism
896
Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
896
Glucose Absorption Into the Small Intestine
31.6K
Complex carbohydrates consumed cannot be absorbed into the small intestine in their original form. First, they must be hydrolyzed to a monosaccharide form such as glucose or galactose. These monosaccharides are then transported across the intestinal membrane and into the blood via transcellular transport. The intestinal epithelial cells allow the movement of these monosaccharides with a defined 'entry' through membrane transporter proteins present on their apical membrane and...
31.6K
Oral Hypoglycemic Agents: Biguanides and Glitazones
188
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
188


